Ubs Oconnor LLC Harrow Health, Inc. Transaction History
Ubs Oconnor LLC
- $1.46 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.2MCall Options Held
844KPut Options Held
698K-
Opaleye Management Inc. Boston, MA3.99MShares$124 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$67.1 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$66.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$57.9 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$22.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $839M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...